Khaitan & Co. advised Bionpharma Health, Inc. on the deal. Bionpharma Health, Inc. (a subsidiary of Bionpharma, Inc, USA) executed the sale of business including the NPNC...
Bionpharma Health’s Joint Venture with Orchid Pharma
Zeta’s $250 Million Series C Funding Round
Khaitan & Co advised Softbank in the deal. Zeta, a banking tech startup, has become the latest unicorn after raising $250 million in a Series C...